Closing Bell: Medicenna Therapeutics Corp down on Friday (MDNA)

Today during trading, Medicenna Therapeutics Corp stock opened at $2.21 and closed at $2.26. Intraday prices ranged from a low of $2.14 to a high of $2.37.

Shares dipped -0.88% from the previous day's close of $2.28.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 81,146 shares was traded during the session, with total trades of 215. On average, Medicenna Therapeutics Corp has traded 88,950 shares in the last five days and 124,080 year-to-date.

Trading across the entire TSX saw 432 price advancers against 4,843 declines and 43 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 296.49% in the last year, while they have risen 438.10% year-to-date.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $169.00 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Medicenna Therapeutics Corp has an average recommendation of "Strong Buy" based on 2.00 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..